Home > PE Ratio > IPCA LABORATORIES

IPCA LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of IPCA LABORATORIES is 34.35.

Share Price ₹1,613.1Jun 11,2026
Market Cap ₹40,923.1 Cr
Earnings-TTM₹1,191.4 CrTTM-Consolidated Results
Price/Earnings34.35xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of IPCA LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of IPCA LABORATORIES is calculated as :

Current Market Cap [ ₹40,923.1 Cr] as on Jun 11,2026

(/) Earnings [ ₹1,191.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 34.35x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for IPCA LABORATORIES , the investors are currently willing to pay 34.35 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of IPCA LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of IPCA LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of IPCA LABORATORIES


PE Ratio Performance Analysis for IPCA LABORATORIES

- IPCA LABORATORIES 's latest p/e ratio is 34.35x.

- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 38.74x.

- IPCA LABORATORIES 's operated at median p/e ratio of 43.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2024 at 57.39x.

- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 10.59x.


How does IPCA LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
IPCA LABORATORIES 1,191.3734.3540,923.1
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5037.23430,513.0
DIVIS LABORATORIES LTD2,568.0068.76176,570.0
TORRENT PHARMACEUTICALS LTD2,138.0072.34154,670.0
CIPLA LTD3,869.7928.87111,725.0
DR REDDYS LABORATORIES LTD4,144.2025.68106,424.0
MANKIND PHARMA LTD1,926.4150.8497,948.2
LUPIN LTD5,355.4719.41103,975.0
ZYDUS LIFESCIENCES LTD5,026.4022.13111,254.0
AUROBINDO PHARMA LTD3,501.4524.0684,241.1
LAURUS LABS LTD889.8584.4275,121.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs IPCA LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.41x
Max industry PE 84.42x
Median industry PE 34.35x
Average industry PE 42.55x



You may also like the below Video Courses